Patents by Inventor Sigmund E. Lasker

Sigmund E. Lasker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090275543
    Abstract: This invention provides a composition comprising a depolymerized glycosaminoglycan or derivative thereof covalently linked to a bile acid. This invention also provides a pharmaceutical composition comprising a depolymerized glycosaminoglycan or derivative thereof covalently linked to a bile acid and a pharmaceutically acceptable carrier. Finally, this invention provides a method for orally delivering heparin to a subject comprising administering to the subject a pharmaceutically effective amount of a pharmaceutical composition comprising a glycosaminoglycan or derivative thereof covalently linked to a bile acid and (b) a pharmaceutically acceptable carrier.
    Type: Application
    Filed: February 4, 2009
    Publication date: November 5, 2009
    Inventors: Sigmund E. Lasker, Biswajit Lahiri
  • Patent number: 5571521
    Abstract: Compositions containing silver ammonium phenytoin complex and a phenytoin are usefully employed, particularly when applied topically, for the treatment of animal or human tissue, for wound healing and are useful in wound dressing preparations for the prevention or treatment of infections. The compositions are usefully applied by direct topical application to the wound or tissue to be treated or may be directly applied to the wound or tissue or incorporated in or coated on a dressing, such as a bandage.
    Type: Grant
    Filed: February 13, 1995
    Date of Patent: November 5, 1996
    Inventor: Sigmund E. Lasker
  • Patent number: 5439903
    Abstract: Stable, organometallic complexes of 5,5-diphenyl-2,4 imidazolidenedione (diphenyl hydantoin) are versatile biocides, effective when applied topically or parenterally to animal tissue, and when applied topically to plants. The diphenyl Hydantoin complexes are seen to prevent animal and plant tissue infections, and may be combined with other materials to inhibit infection.
    Type: Grant
    Filed: January 7, 1994
    Date of Patent: August 8, 1995
    Inventor: Sigmund E. Lasker
  • Patent number: 5339814
    Abstract: The present invention provides a process for visualizing tissue metabolism in a subject comprising injecting .sup.17 O.sub.2 into the peritoneal cavity of a subject and detecting formed H.sub.2.sup.17 O in tissues of the subject. The .sup.17 O.sub.2 is injected as a gas or as microbubbles formed from an aqueous protein solution.
    Type: Grant
    Filed: April 14, 1992
    Date of Patent: August 23, 1994
    Inventor: Sigmund E. Lasker
  • Patent number: 5298624
    Abstract: Stable, organometallic complexes of 5,5-diphenyl-2,4 imidazolidenedione (diphenyl hydantoin) are versatile biocides, effective when applied topically or parenterally to animal tissue, and when applied topically to plants. The diphenyl Hydantoin complexes are seen to prevent animal and plant tissue infections, and may be combined with other materials to inhibit infection.
    Type: Grant
    Filed: November 12, 1992
    Date of Patent: March 29, 1994
    Inventor: Sigmund E. Lasker
  • Patent number: 4996041
    Abstract: A diagnostic imaging agent is provided for use in conjunction with a magnetic resonance imaging system for the imaging of spacial oxygen distribution in tissue. The imaging agent is comprised of a complex of oxygen-17, a biologically acceptable liquid carrier, such as a perfluorinated compound, and an emulsifying agent, and wherein the agent has an average particle size of less than about 0.6 microns, and an ionic composition essentially equal to that of blood. Useful information can be obtained, and in certain instances, therapy administered, by a non-envasive imaging technique relative to tissue perfusion by .sup.19 F-NMR (imaging of .sup.19 F) and oxygen utilization by .sup.1 H-NMR (imaging of H.sub.2.sup.17 O as a metabolite).
    Type: Grant
    Filed: August 19, 1988
    Date of Patent: February 26, 1991
    Inventors: Toshiyuki Arai, Pradeep M. Gupte, Sigmund E. Lasker
  • Patent number: 4533549
    Abstract: The object of the invention is to provide a new antithrombotic agent.Coagulation of blood acts through a cascade of stages, the mechanisms and interaction of which have not been fully clarified. The present invention provides a derivative of heparin which can be administered orally, topically, or parenterally to antagonize the effect of factor Xa to a greater extent than commercial porcine heparin. In addition, the derivative has insignificant USP anticoagulant and platelet aggregating activities.The heparin derivative according to the invention, has a molecular weight of from about 2,500 to about 4,000 daltons, gives a positive metachromatic test for sulfated polysaccharides. Preferably, when isolated as the sodium salt, the derivative contains by elemental analysis about 26.2% carbon, 4.33% hydrogen, 1.98% nitrogen, 7.1% sulfur, and 9.8% sodium, the molar ratio C:N:S:Na being about 10:1.5:2:4.
    Type: Grant
    Filed: February 17, 1984
    Date of Patent: August 6, 1985
    Inventor: Sigmund E. Lasker